| For: | Campo JAD, Romero-Gómez M. Steatosis and insulin resistance in hepatitis C: A way out for the virus? World J Gastroenterol 2009; 15(40): 5014-5019 [PMID: 19859993 DOI: 10.3748/wjg.15.5014] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i40/5014.htm |
| Number | Citing Articles |
| 1 |
Ángela Rojas, Jose A. Del Campo, Sophie Clement, Matthieu Lemasson, Marta García-Valdecasas, Antonio Gil-Gómez, Isidora Ranchal, Birke Bartosch, Juan D. Bautista, Arielle R. Rosenberg, Francesco Negro, Manuel Romero-Gómez. Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets. Scientific Reports 2016; 6(1) doi: 10.1038/srep31777
|
| 2 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2) doi: 10.1111/apt.15575
|
| 3 |
Imran Hasanoglu, Antonio Rivero-Juárez, Gülşen Özkaya Şahin. When Metabolic Dysfunction-Associated Steatotic Liver Disease Meets Viral Hepatitis. Journal of Clinical Medicine 2025; 14(10) doi: 10.3390/jcm14103422
|
| 4 |
Roland Ivanyi-Nagy, Jean-Luc Darlix. Fuzziness. Advances in Experimental Medicine and Biology 2012; 725 doi: 10.1007/978-1-4614-0659-4_9
|
| 5 |
Ludovico Abenavoli, Mario Masarone, Valentina Peta, Natasa Milic, Nazarii Kobyliak, Samir Rouabhia, Marcello Persico. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. World Journal of Gastroenterology 2014; 20(41): 15233-15240 doi: 10.3748/wjg.v20.i41.15233
|
| 6 |
Saba Riaz, Muhammad Faisal Bashir, Saleem Haider, Naeem Rahid. Association of genotypes with viral load and biochemical markers in HCV-infected Sindhi patients. Brazilian Journal of Microbiology 2016; 47(4) doi: 10.1016/j.bjm.2016.07.014
|
| 7 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1) doi: 10.3390/biology12010023
|
| 8 |
Claire Gondeau, Georges Philippe Pageaux, Dominique Larrey. Hepatitis C virus infection: Are there still specific problems with genotype 3?. World Journal of Gastroenterology 2015; 21(42): 12101-12113 doi: 10.3748/wjg.v21.i42.12101
|
| 9 |
Yun-Feng Yu, Gang Hu, Ke-Ke Tong, Xin-Yu Yang, Jing-Yi Wu, Rong Yu. Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study. World Journal of Diabetes 2024; 15(2): 220-231 doi: 10.4239/wjd.v15.i2.220
Abstract(706) |
Core Tip(1109) |
Full Article(HTML)(3262)
|
Full Article (PDF)-1562K(302)
|
Full Article with Cover (PDF)-1899K(251)
|
Full Article (Word)-1009K(54)
|
Full Article (XML)-134K(178)
|
Audio-1806K(13)
|
Peer-Review Report-202K(198)
|
Answering Reviewers-112K(187)
|
Supplementary Material-368K(190)
|
Times Cited (3)
|
Total Visits (5224)
|
Open
|
| 10 |
Mihai Lazar, Cristina Emilia Chitu, Ecaterina Constanta Barbu. DXA-Derived Body Composition Phenotypes in Men with Chronic Hepatitis C. Sci 2026; 8(9) doi: 10.3390/sci8090223
|
| 11 |
Camila Ripoll Kappel, Nélson A. Kretzmann, Mário Reis Álvares-da-Silva. IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study. International Journal of Hepatology 2012; 2012 doi: 10.1155/2012/698905
|
| 12 |
Yu-Chung Tsao, Jau-Yuan Chen, Wei-Chung Yeh, Yun-Shing Peng, Wen-Cheng Li. Association between visceral obesity and hepatitis C infection stratified by gender: a cross-sectional study in Taiwan. BMJ Open 2017; 7(11) doi: 10.1136/bmjopen-2017-017117
|
| 13 |
Praveen Raman Mishra, Akash Bharti, Ridhi Arora, Irfan Ahmad Mir, V. P. S. Punia. Increased Insulin Resistance in Hepatitis-C Infection—Association with Altered Hepatic Function Testing. Pathophysiology 2022; 29(3) doi: 10.3390/pathophysiology29030024
|
| 14 |
Amal A Mohamed, Samah A Loutfy, James D Craik, Abdel Gawad M Hashem, Ibrahem Siam. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-496
|
| 15 |
Lokesh P. Tripathi, Hiroto Kambara, Kohji Moriishi, Eiji Morita, Takayuki Abe, Yoshio Mori, Yi-An Chen, Yoshiharu Matsuura, Kenji Mizuguchi. Proteomic Analysis of Hepatitis C Virus (HCV) Core Protein Transfection and Host Regulator PA28γ Knockout in HCV Pathogenesis: A Network-Based Study. Journal of Proteome Research 2012; 11(7) doi: 10.1021/pr300121a
|
| 16 |
Mario Frías, Antonio Rivero-Juárez, Isabel Machuca, Ángela Camacho, Antonio Rivero. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities. Expert Review of Precision Medicine and Drug Development 2020; 5(4) doi: 10.1080/23808993.2020.1764346
|
| 17 |
Á. Rojas, J. A. del Campo, M. Maraver, R. Aparcero, M. García‐Valdecasas, M. Diago, I. Carmona, R. J. Andrade, R. Solà, M. Romero‐Gómez. Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro. Journal of Viral Hepatitis 2014; 21(1) doi: 10.1111/jvh.12209
|
| 18 |
Wen‐Cheng Li, Yi‐Yen Lee, I‐Chuan Chen, Cheng Sun, Feng‐Hsiang Chiu, Chung‐Hsun Chuang. Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age. Liver International 2013; 33(8) doi: 10.1111/liv.12224
|
| 19 |
Marcela Pezzoto Laurito, Edison Roberto Parise. Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis. The Brazilian Journal of Infectious Diseases 2013; 17(5) doi: 10.1016/j.bjid.2013.02.009
|
| 20 |
Eman A. Sabet, Asmaa N. Mohammad, Laila M. Yousef, Ahmed R. H. Ahmed, Abeer Sheneef. Insulin Resistance, Visceral Adiposity Index and TyG Index in Genotype-4 Chronic HCV Patients and Their Relation to Hepatic Histopathology. Open Journal of Gastroenterology 2016; 6(10) doi: 10.4236/ojgas.2016.610030
|
| 21 |
Vaia Valiakou, Petros Eliadis, Eirini Karamichali, Ourania Tsitsilonis, John Koskinas, Urania Georgopoulou, Pelagia Foka. Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment. International Journal of Molecular Sciences 2021; 22(15) doi: 10.3390/ijms22157961
|
| 22 |
Oana Irina Gavril, Irina Mihaela Esanu, Otilia Gavrilescu, Raluca Popa, Maria Luiza Cobzeanu, Diana Tatarciuc, Teodor Vasilcu, Andrei Drugescu, Radu Sebastian Gavril, Florin Mitu. Liver Steatosis and its Implications in Patients with Chronic Viral Hepatitis C. Internal Medicine 2023; 20(1) doi: 10.2478/inmed-2023-0235
|
| 23 |
Geneviève F. Desrochers, Allison R. Sherratt, David R. Blais, Neda Nasheri, Zhibin Ning, Daniel Figeys, Natalie K. Goto, John Paul Pezacki. Profiling Kinase Activity during Hepatitis C Virus Replication Using a Wortmannin Probe. ACS Infectious Diseases 2015; 1(9) doi: 10.1021/acsinfecdis.5b00083
|
| 24 |
Heather L. Stevenson, Netanya S. Utay. Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era. Tropical Diseases, Travel Medicine and Vaccines 2016; 2(1) doi: 10.1186/s40794-016-0038-5
|
| 25 |
Lokesh P. Tripathi, Hiroto Kambara, Yi-An Chen, Yorihiro Nishimura, Kohji Moriishi, Toru Okamoto, Eiji Morita, Takayuki Abe, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Understanding the Biological Context of NS5A–Host Interactions in HCV Infection: A Network-Based Approach. Journal of Proteome Research 2013; 12(6) doi: 10.1021/pr3011217
|
| 26 |
Alessandro Federico, Mario Masarone, Marco Romano, Marcello Dallio, Valerio Rosato, Marcello Persico. Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study. Hepatitis Monthly 2015; 15(6) doi: 10.5812/hepatmon.15(6)2015.18640
|
| 27 |
Feray Ferda Senol, Ilkay Bahcecı, Sermin Algül, Ozlem Aytac, Arzu Şenol, Yusuf Çelik. Investigation of Changes in Irisin and Nesfatin-1 Levels in Chronic Viral Hepatitis. Journal of Clinical Medicine 2026; 15(9) doi: 10.3390/jcm15093209
|
| 28 |
Woo Jin Chung. Chronic Hepatitis C and Insulin Resistance. The Korean Journal of Gastroenterology 2012; 59(4) doi: 10.4166/kjg.2012.59.4.268
|
| 29 |
. 2015; doi: 10.70675/dd7e70c4zf357z4e69z9135zcfe53dd60cce
|
| 30 |
Maria Perticone, Sofia Miceli, Raffaele Maio, Benedetto Caroleo, Angela Sciacqua, Eliezer Joseph Tassone, Laura Greco, Orietta Staltari, Giorgio Sesti, Francesco Perticone. Chronic HCV infection increases cardiac left ventricular mass index in normotensive patients. Journal of Hepatology 2014; 61(4) doi: 10.1016/j.jhep.2014.05.032
|
| 31 |
Emilio González-Reimers, Geraldine Quintero-Platt, Melchor Rodríguez-Gaspar, Remedios Alemán-Valls, Onán Pérez-Hernández, Francisco Santolaria-Fernández. Liver steatosis in hepatitis C patients. World Journal of Hepatology 2015; 7(10): 1337-1346 doi: 10.4254/wjh.v7.i10.1337
|
| 32 |
W. Chen, G. Tomlinson, M. Krahn, J. Heathcote. Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma. Journal of Viral Hepatitis 2012; 19(8) doi: 10.1111/j.1365-2893.2012.01583.x
|
| 33 |
Chandrasekar Palaniswamy, Wilbert S. Aronow, Rishi Sukhija, Tarun Chugh, Navi Ramdeen, Kumar Kalapatapu, Melvin B. Weiss, Anthony L. Pucillo, Craig E. Monsen. Major Adverse Cardiac Events in Patients With Hepatitis C Infection Treated With Bare‐Metal Versus Drug‐Eluting Stents. Clinical Cardiology 2010; 33(6) doi: 10.1002/clc.20764
|
| 34 |
A. C. Cardoso, R. M. Perez, C. de Figueiredo‐Mendes, N. Carvalho Leite, H. S. Moraes‐Coelho, C. A. Villela‐Nogueira. Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP). Journal of Viral Hepatitis 2018; 25(11) doi: 10.1111/jvh.12930
|
| 35 |
Marco Arrese, Arnoldo Riquelme, Alejandro Soza. Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implications. Annals of Hepatology 2010; 9 doi: 10.1016/S1665-2681(19)31735-1
|
| 36 |
|
| 37 |
Oana Irina Gavril, Irina Mihaela Esanu, Ioana Madalina Zota, Iolanda Valentina Popa, Lidia Iuliana Arhire, Diana Tatarciuc, Alexandra Mastaleru, Andrei Drugescu, Radu Sebastian Gavril, Mariana Graur, Florin Mitu. Hepatic Steatosis in Patients with Chronic Viral Hepatitis C Treated with Direct Acting Antivirals. Internal Medicine 2023; 20(2) doi: 10.2478/inmed-2023-0247
|
| 38 |
Kamila Wójcik, Anna Piekarska, Alina Dąbrowicz, Marta Stasiak, Katarzyna Gawryś, Elżbieta Jabłonowska. Hepatic Expression of Phosphorylated Kinase Akt and Glycogen Synthase Kinase-3 Isoforms in Patients with Chronic Hepatitis C. Viral Immunology 2019; 32(4) doi: 10.1089/vim.2018.0141
|
| 39 |
Paul Lamb, Stephen Harrison. Metabolic Syndrome and HCV: Where Do We Stand in 2010?. Current Hepatitis Reports 2010; 9(3) doi: 10.1007/s11901-010-0044-4
|
| 40 |
Keyur Patel, Alexander J Thompson, Wan‐Long Chuang, Chuan‐Mo Lee, Chen‐Yuan Peng, Ganesananthan Shanmuganathan, Satawat Thongsawat, Tawesak Tanwandee, Varocha Mahachai, Chutima Pramoolsinsap, Mong Cho, Kwang Hyup Han, Samir R Shah, Graham R Foster, Paul J Clark, Erik Pulkstenis, G. Mani Subramanian, John G McHutchison. Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients. Journal of Gastroenterology and Hepatology 2011; 26(7) doi: 10.1111/j.1440-1746.2011.06722.x
|
| 41 |
Marianna Lakatos, Krisztina Hagymási, Gabriella Lengyel. Fatty liver and hepatitis C virus infection. Orvosi Hetilap 2011; 152(38) doi: 10.1556/OH.2011.29209
|
| 42 |
Anca Trifan, Ermina Stratina, Adrian Rotaru, Remus Stafie, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Catalin Sfarti, Camelia Cojocariu, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Carol Stanciu. Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response. Diagnostics 2022; 12(3) doi: 10.3390/diagnostics12030702
|
| 43 |
M Wiśniewska-Ligier, A Konopka, T Woźniakowska-Gęsicka. Lipid and carbohydrate parameters in children with chronic hepatitis C. Advances in Medical Sciences 2011; 56(2) doi: 10.2478/v10039-011-0048-5
|
| 44 |
Walid Sasi, Anup K. Sharma, Kefah Mokbel. The Role of Suppressors of Cytokine Signalling in Human Neoplasms. Molecular Biology International 2014; 2014 doi: 10.1155/2014/630797
|
| 45 |
Lokesh P Tripathi, Chikako Kataoka, Shuhei Taguwa, Kohji Moriishi, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Network based analysis of hepatitis C virus Core and NS4B protein interactions. Molecular BioSystems 2010; 6(12) doi: 10.1039/C0MB00103A
|
| 46 |
Luigi E Adinolfi, Luciano Restivo, Aldo Marrone. The predictive value of steatosis in hepatitis C virus infection. Expert Review of Gastroenterology & Hepatology 2013; 7(3) doi: 10.1586/egh.13.7
|
| 47 |
Fadi Rzouq, Mojtaba Olyaee, Fares Alahdab. Statins and Hepatitis C Virus Infection: An Old Therapy With New Scope. The American Journal of the Medical Sciences 2014; 348(5) doi: 10.1097/MAJ.0000000000000291
|
| 48 |
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E. Butler. Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2. Metabolism 2024; 156 doi: 10.1016/j.metabol.2024.155917
|